Literature DB >> 9019355

Surgical resection of metastatic liver tumors.

J Kavolius1, Y Fong, L H Blumgart.   

Abstract

The liver is a common site of metastatic cancers. Abundant data now support surgical resection as the treatment of choice for metastatic colorectal cancer to the liver. For symptomatic neuroendocrine tumors, resection also is a useful palliative therapy. Roles for resection of metastatic cancer from other primary sites have yet to be defined.

Entities:  

Mesh：

Year:  1996        PMID： 9019355

Source DB:  PubMed          Journal:  Surg Oncol Clin N Am        ISSN： 1055-3207            Impact factor:   3.495


  14 in total

1.  Selective metastatic tumor labeling with green fluorescent protein and killing by systemic administration of telomerase-dependent adenoviruses.

Authors:  Hiroyuki Kishimoto; Yasuo Urata; Noriaki Tanaka; Toshiyoshi Fujiwara; Robert M Hoffman
Journal:  Mol Cancer Ther       Date:  2009-11-03       Impact factor: 6.261

2.  Boron neutron capture therapy (BNCT) for liver metastasis in an experimental model: dose–response at five-week follow-up based on retrospective dose assessment in individual rats.

Authors:  Emiliano C C Pozzi; Verónica A Trivillin; Lucas L Colombo; Andrea Monti Hughes; Silvia I Thorp; Jorge E Cardoso; Marcela A Garabalino; Ana J Molinari; Elisa M Heber; Paula Curotto; Marcelo Miller; Maria E Itoiz; Romina F Aromando; David W Nigg; Amanda E Schwint
Journal:  Radiat Environ Biophys       Date:  2013-11       Impact factor: 1.925

3.  Clinicopathologic and treatment-related factors influencing recurrence and survival after hepatic resection of intrahepatic cholangiocarcinoma: a 19-year experience from an established Australian hepatobiliary unit.

Authors:  Akshat Saxena; Terence C Chua; Anik Sarkar; Francis Chu; David L Morris
Journal:  J Gastrointest Surg       Date:  2010-05-14       Impact factor: 3.452

4.  Boron neutron capture therapy (BNCT) for liver metastasis: therapeutic efficacy in an experimental model.

Authors:  Emiliano C C Pozzi; Jorge E Cardoso; Lucas L Colombo; Silvia Thorp; Andrea Monti Hughes; Ana J Molinari; Marcela A Garabalino; Elisa M Heber; Marcelo Miller; Maria E Itoiz; Romina F Aromando; David W Nigg; Jorge Quintana; Verónica A Trivillin; Amanda E Schwint
Journal:  Radiat Environ Biophys       Date:  2012-04-28       Impact factor: 1.925

5.  Prognostic factors and evaluation of surgical management of hepatic metastases from colorectal origin: a 10-year single-institute experience.

Authors:  Eduard L A R Mutsaerts; Serge van Ruth; Frans A N Zoetmulder; Emiel J T Rutgers; Augustinus A M Hart; Frits van Coevorden
Journal:  J Gastrointest Surg       Date:  2005-02       Impact factor: 3.452

6.  The impact of 18F-FDG PET/CT in patients with liver metastases.

Authors:  Siew C Chua; Ashley M Groves; Irfan Kayani; Leon Menezes; Svetislav Gacinovic; Yong Du; Jamshed B Bomanji; Peter J Ell
Journal:  Eur J Nucl Med Mol Imaging       Date:  2007-08-23       Impact factor: 9.236

7.  Hepatic resection but not radiofrequency ablation results in tumor growth and increased growth factor expression.

Authors:  Kenneth Meredith; Dieter Haemmerich; Chen Qi; David Mahvi
Journal:  Ann Surg       Date:  2007-05       Impact factor: 12.969

8.  An in vivo rat model for early development of colorectal cancer metastasis to liver.

Authors:  John H P Robertson; Shi Yu Yang; Arthur M Iga; Alexander M Seifalian; Marc C Winslet
Journal:  Int J Exp Pathol       Date:  2008-12       Impact factor: 1.925

Review 9.  In vivo models for early development of colorectal liver metastasis.

Authors:  John H P Robertson; Sandip Sarkar; Shi Yu Yang; Alexander M Seifalian; Marc C Winslet
Journal:  Int J Exp Pathol       Date:  2007-12-11       Impact factor: 1.925

10.  Microwave ablation of hepatic tumors using dual-loop probes: results of a phase I clinical trial.

Authors:  Kenneth Meredith; Fred Lee; Mary Beth Henry; Thomas Warner; David Mahvi
Journal:  J Gastrointest Surg       Date:  2005-12       Impact factor: 3.267
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.